Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Highly Accessed Research article

Validation of the chronic disease score-infectious disease (CDS-ID) for the prediction of hospital-associated clostridium difficile infection (CDI) within a retrospective cohort

Vanessa Stevens1*, Cathleen Concannon2, Edwin van Wijngaarden2 and Jessina McGregor3

Author Affiliations

1 Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT, 84108, USA

2 University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

3 Department of Pharmacy Practice, Oregon Health and Science University College of Pharmacy, Portland, OR, USA

For all author emails, please log on.

BMC Infectious Diseases 2013, 13:150  doi:10.1186/1471-2334-13-150

Published: 26 March 2013

Abstract

Background

Aggregate comorbidity scores are useful for summarizing risk and confounder control in studies of hospital-associated infections. The Chronic Disease Score – Infectious Diseases (CDS-ID) was developed for this purpose, but it has not been validated for use in studies of Clostridium difficile Infection (CDI). The aim of this study was to assess the discrimination, calibration and potential for confounder control of CDS-ID compared to age alone or individual comorbid conditions.

Methods

Secondary analysis of a retrospective cohort study of adult inpatients with 2 or more days of antibiotic exposure at a tertiary care facility during 2005. Logistic regression models were used to predict the development of CDI up to 60 days post-discharge. Model discrimination and calibration were assessed using the c-statistic and Hosmer-Lemeshow (HL) tests, respectively. C-statistics were compared using chi-square tests.

Results

CDI developed in 185 out of 7,792 patients. The CDS-ID was a better standalone predictor of CDI than age (c-statistic 0.653 vs 0.609, P=0.04). The best discrimination was observed when CDS-ID and age were both used to predict CDI (c-statistic 0.680). All models had acceptable calibration (P>0.05).

Conclusion

The CDS-ID is a valid tool for summarizing risk of CDI associated with comorbid conditions.

Keywords:
Comorbidity score; Clostridium difficile infection; Validation; Chronic disease score; Infectious disease (CDS-ID)